Table Of Content

PAIN Pain 113 (2005) 431-434 www.elsevier.com/locate/pain Author Index to Volume 113 (2005) Adelson, M., see Peles, E., 113 340 Clark, A.J., see Sullivan, M.J.L., 113 310 Aiken, L.S., see Ruehlman, L.S., 113 82 Clayton, C.C., see Morgan, M.M., 113 91 Ait-Belgnaoui, A., Bradesi, S., Fioramonti, J., Theodorou, V., Bueno, L., Conklin, D., see Obata, H., 113 271 Acute stress-induced hypersensitivity to colonic distension depends Conklin, D.R., see Martin, T.J., 113 376 upon increase in paracellular permeability: role of myosin light chain Convers, P., see Montes, C., 113 223 kinase, 113 141 Cousins, M.J., see Blyth, F.M., 113 285 Albers, K.M., see Molliver, D.C., 113 277 Cowan, P., see Dworkin, R.H., 113 9 Allen, R.R., see Dworkin, R.H., 113 9 Crane, P., see Von Korff, M., 113 331 Anderson, K.O., Role of cutpoints: why grade pain intensity?, 113 5 Crombez, G., see Eccleston, C., 113 7 Anzenhofer, S., see Sycha, T., 113 316 Crombez, G., see Gheldof, E.L.M., 113 71 Arendt-Nielsen, L., see Ge, H.-Y., 113 134 Dahl, J.B., see Duedahl, T.H., 113 360 Bach, F.W., Jensen, T.S., Sindrup, S.H., Rasmussen, P.V., Response letter Dai, Y., see Mizushima, T., 113 51 regarding Thompson, 113 245 Davis, B.M., see Molliver, D.C., 113 277 Bakalkin, G., see Tan-No, K., 113 301 Davis, K.D., see Kwan, C.L., 113 160 Baker, M.D., see Stirling, L.C., 113 27 DeLander, G.E., see Wu, W.-P., 113 395 Balderson, B.H.K., see Von Korff, M., 113 323 Dey, D.D., Landrum, O., Oaklander, A.L., Central neuropathic itch from Bantel, C., see Ma, W., 113 386 spinal-cord cavernous hemangioma: a human case, a possible animal Bell, A.C., see Gilron, I., 113 191 model, and hypotheses about pathogenesis, 113 233 Bellamy, N., see Dworkin, R.H., 113 9 Diamant, N.E., see Kwan, C.L., 113 160 Berry, S., see Von Korff, M., 113 323 Dickenson, A.H., see Hansson, P.T., 113 251 Bianchini, K.J., see Greve, K.W., 113 245 Dickenson, A.H., see Stirling, L.C., 113 27 Bjoro, T., see Hagen, K., 113 416 Dionne, R., see Dworkin, R.H., 113 9 Blyth, F.M., March, L.M., Nicholas, M.K., Cousins, M.J., Self-manage- Dirks, J., see Duedahl, T.H., 113 360 ment of chronic pain: a population-based study, 113 285 Duedahl, T.H., Dirks, J., Petersen, K.B., Romsing, J., Larsen, N.-E., Dahl, Boivin, M., see Strigo, I.A., 113 255 J.B., Intravenous dextromethorphan to human volunteers: relationship Borszcz, G.S., see Harte, $.E., 113 405 between pharmacokinetics and anti-hyperalgesic effect, 113 360 Bovim, G., see Hagen, K., 113 416 Duncan, G.H., see Strigo, I.A., 113 255 Bowsher, D., Pain, 113 430 Dworkin, R.H., Turk, D.C., Farrar, J.T., Haythornthwaite, J.A., Jensen, M.P., Boyer-Quick, J.S., see Morgan, M.M., 113 91 Katz, N.P., Kerns, R.D., Stucki, G., Allen, R.R., Bellamy, N., Carr, D.B., Brack, A., see Puehler, W., 113 427 Chandler, J., Cowan, P., Dionne, R., Galer, B.S., Hertz, S., Jadad, A.R., Bradesi, S., see Ait-Belgnaoui, A., 113 141 Kramer, L.D., Manning, D.C., Martin, S.,. McCormick, C.G., McDermott, Brandenburg, N., see Von Korff, M., 113 331 M.P., McGrath, P., Quessy, S., Rappaport, B.A., Robbins, W., Robinson, Buechler, N., see Martin, T.J., 113 376 J.P., Rothman, M., Royal, M.A., Simon, L., Stauffer, J.W., Stein, W., Bueno, L., see Ait-Belgnaoui, A., 113 141 Tollett, J., Wernicke, J., Witter. J., Core outcome measures for chronic Buffington, A.L.H., Hanlon, C.A., McKeown, M.J., Acute and persistent pain clinical trials: IMMPACT recommendations, 113 9 pain modulation of attention-related anterior cingulate fMRI activa- tions, 113 172 Eccleston, C., Crombez, G., Attention and pain: merging behavioural and Burkey, T.H., see Fehrenbacher, J.C., 113 113 neuroscience investigations, 113 7 Bushnell, M.C., see Strigo, 1.A., 113 255 Edwards, R.R., see Campbell, C.M., 113 20 Eichler, H.-G., see Sycha, T., 113 316 Campbell, C.M., Edwards, R.R., Fillingim, R.B., Ethnic differences in Eisenach, J.C., see Ma, W., 113 386 responses to multiple experimental pain stimuli, 113 20 Eisenach, J.C., see Martin, T.J., 113 376 Carr, D.B., see Dworkin, R.H., 113 9 Eisenach, J.C., see Obata, H., 113 271 Chandler, J., see Dworkin, R.H., 113 9 Eisenberg, E., Response to Reuben SS: *‘The prevention of post-surgical Chibnall, J.T., Tait, R.C., Confirmatory factor analysis of the Pain Cata- neuralgia’, 113 243 strophizing Scale in African American and Caucasian Workers’ Eisenberg, E., Chistyakov, A.V., Yudashkin, M., Kaplan, B., Hafner, H.. Compensation claimants with low back injuries, 113 369 Feinsod, M., Evidence for cortical hyperexcitability of the affected limb Chistyakov, A.V., see Eisenberg, E., 113 99 representation area in CRPS: a psychophysical and_ transcranial Chizh, B., see Sycha, T., 113 316 magnetic stimulation study, 113 99 Christidis, N., Kopp, S., Ernberg, M., The effect on mechanical pain thresh- Elia, N., Tramér, M.R., Ketamine and postoperative pain—a quantitative old over human muscles by oral administration of granisetron and systematic review of randomised trials, 113 61 diclofenac-sodium, 113 265 Elliott, A.M., see Smith, B.H., 113 249 Clark, A.J., see Lynch, M.E., 113 240 Ernberg, M., see Christidis, N., 113 265 doi: 10.1016/S0304-3959(04)00610-4 432 Author Index to Volume 113 (2005) 431-434 Farrar, J.T., see Dworkin, R.H., 113 9 Katz, N.P., see Dworkin, R.H., 113 9 Fehrenbacher, J.C., Burkey, T.H., Nicol, G.D., Vasko, M.R., Tumor necro- Kender, R.G., see Harte, S.E., 113 405 sis factor a and interleukin-1B stimulate the expression of cyclooxy- Kerns, R.D., see Dworkin, R.H., 113 9 genase II but do not alter prostaglandin E, receptor mRNA levels in Kessler, R., see Von Korff, M., 113 331 cultured dorsal root ganglia cells, 113 113 Kopf, A., see Puehler, W., 113 427 Feinsod, M., see Eisenberg, E., 113 99 Kopp, S., see Christidis, N., 113 265 Fillingim, R.B., see Campbell, C.M., 113 20 Kramer, L.D., see Dworkin, R.H., 113 9 Fioramonti, J., see Ait-Belgnaoui, A., 113 141 Kunz, N.R., see Rowbotham, M.C., 113 248 Fitzgerald, C., see Grunau, R.E., 113 293 Kwan, C.L., Diamant, N.E., Mikula, K., Davis, K.D., Characteristics of Forlani, G., see Stirling, L.C., 113 27 rectal perception are altered in irritable bowel syndrome, 113 160 Fredholm, B.B., see Wu, W.-P., 113 395 Frot, M., see Montes, C., 113 223 LaMotte, R.H., see Ma, C., 113 106 Fukuoka, T., see Mizushima, T., 113 51 Landrum, O., see Dey, D.D., 113 233 Lane, M., see Von Korff, M., 113 331 Galer, B.S., see Dworkin, R.H., 113 9 Lang, B.A., see Reid, G.J., 113 201 Garcia-Larrea, L., see Montes, C., 113 223 Larsen, N.-E., see Duedahl, T.H., 113 360 Ge, H.-Y., Madeleine, P., Arendt-Nielsen, L., Gender differences in pain Lehr, S., see Sycha, T., 113 316 modulation evoked by repeated injections of glutamate into the human Lei, D., see Rowbotham, M.C., 113 248 trapezius muscle, 113 134 Levine, J.D., see Parada, C.A., 113 185 Gheldof, E.L.M., Vinck, J., Vlaeyen, J.W.S., Hidding, A., Crombez, G., Lin, E.H.B., see Von Korff, M., 113 323 The differential role of pain, work characteristics and pain-related fear Lindsay, J., see Molliver, D.C., 113 277 in explaining back pain and sick leave in occupational settings, 113 71 Lévdahl, C., see Wu, W.-P., 113 395 Gilron, I., Orr, E., Tu, D., O’ Neill, J.P., Zamora, J.E., Bell, A.C., A placebo- Luyten, P., see Van Houdenhove, B., 113 238 controlled randomized clinical trial of perioperative administration of Lynch, M.E., see Sullivan, M.J.L., 113 310 gabapentin, rofecoxib and their combination for spontaneous and move- Lynch, M.E., Clark, A.J., Beware somatization et al., 113 240 ment-evoked pain after abdominal hysterectomy, 113 191 Goli, V., see Rowbotham, M.C., 113 248 Ma, C., LaMotte, R.H., Enhanced excitability of dissociated primary Gordon, J., see Peles, E., 113 340 sensory neurons after chronic compression of the dorsal root ganglion Greve, K.W., Bianchini, K.J., Response to Thompson and Sterling, 113 245 in the rat, 113 106 Grunau, R.E., Holsti, L., Haley, D.W., Oberlander, T., Weinberg, J., Soli- Ma, W., Zhang, Y., Bantel, C., Eisenach, J.C., Medium and large injured mano, A., Whitfield, M.F., Fitzgerald, C., Yu, W., Neonatal procedural dorsal root ganglion cells increase TRPV-1, accompanied by increased pain exposure predicts lower cortisol and behavioral reactivity in a2C-adrenoceptor co-expression and functional inhibition by clonidine, preterm infants in the NICU, 113 293 113 386 Gustorff, B., see Sycha, T., 113 316 Maarrawi, J., see Montes, C., 113 223 Madeleine, P., see Ge, H.-Y., 113 134 Hafner, H., see Eisenberg, E., 113 99 Magnin, M., see Montes, C., 113 223 Hagen, K., Bj@ro, T., Zwart, J.-A., Svebak, S., Bovim, G., Stovner, L.J., Do Manning, D.C., see Dworkin, R.H., 113 9 high TSH values protect against chronic musculoskeletal complaints? March, L.M., see Blyth, F.M., 113 285 The Nord-Trondelag Health Study (HUNT), 113 416 Marinova, Z., see Tan-No, K., 113 301 Haley, D.W., see Grunau, R.E., 113 293 Martin, S., see Dworkin, R.H., 113 9 Halldner, L., see Wu, W.-P., 113 395 Martin, T.J., Zhang, Y., Buechler, N., Conklin, D.R., Eisenach, J.C., Han, J.S., Neugebauer, V., mGluR1 and mGluRS5 antagonists in the amyg- Intrathecal morphine and ketorolac analgesia after surgery: comparison dala inhibit different components of audible and ultrasonic vocaliza- of spontaneous and elicited responses in rats, 113 376 tions in a model of arthritic pain, 113 211 Mashimo, T., see Mizushima, T., 113 51 Handwerker, H., see Ikoma, A., 113 148 Matthews, E.A., see Stirling, L.C., 113 27 Hanlon, C.A., see Buffington, A.L.H., 113 172 Mauguiere, F., see Montes, C., 113 223 Hansson, P.T., Dickenson, A.H., Pharmacological treatment of peripheral McCormick, C.G., see Dworkin, R.H., 113 9 neuropathic pain conditions based on shared commonalities despite McCracken, L.M., Social context and acceptance of chronic pain: the role multiple etiologies, 113 251 of solicitous and punishing responses, 113 155 Hao, J.-X., see Wu, W.-P., 113 395 McDermott, M.P., see Dworkin, R.H., 113 9 Harte, S.E., Kender, R.G., Borszcz, G.S., Activation of 5-HT,, and 5-HT; McGrath, P., see Dworkin, R.H., 113 9 receptors in the parafascicular nucleus suppresses the affective reaction McGrath, P.J., see Reid, G.J., 113 201 of rats to noxious stimulation, 113 405 McKeown, M.J., see Buffington, A.L.H., 113 172 Haythornthwaite, J.A., see Dworkin, R.H., 113 9 McQuay, H., Consensus on outcome measures for chronic pain trials, 113 | Hertz, S., see Dworkin, R.H., 113 9 Merskey, H., Distortion of the biopsychosocial approach, 113 240 Hidding, A., see Gheldof, E.L.M., 113 71 Miaskowski, C., see Paul, S.M., 113 37 Holsti, L., see Grunau, R.E., 113 293 Miglioretti, D.L., see Von Korff, M., 113 323 Miglioretti, D.L., see Von Korff, M., 113 331 Ikoma, A., Handwerker, H., Miyachi, Y., Schmelz, M., Electrically evoked Mikula, K., see Kwan, C.L., 113 160 itch in humans, 113 148 Miyachi, Y., see Ikoma, A., 113 148 Mizushima, T., Obata, K., Yamanaka, H., Dai, Y., Fukuoka, T., Tokunaga, Jadad, A.R., see Dworkin, R.H., 113 9 A., Mashimo, T., Noguchi, K., Activation of p38 MAPK in primary Jensen, M.P., see Dworkin, R.H., 113 9 afferent neurons by noxious stimulation and its involvement in the Jensen, T.S., see Bach, F.W., 113 245 development of thermal hyperalgesia, 113 51 Molliver, D.C., Lindsay, J., Albers, K.M., Davis, B.M., Overexpression of Kaplan, B., see Eisenberg, E., 113 99 NGF or GDNF alters transcriptional plasticity evoked by inflammation, Karoly, P., see Ruehlman, L.S., 113 82 113 277 Author Index to Volume 113 (2005) 431-434 433 Montes, C., Magnin, M., Maarrawi, J., Frot, M., Convers, P., Mauguiere, F., Rowbotham, M.C., Goli, V., Kunz, N.R., Lei, D., Corrigendum to **Venla- Garcia-Larrea, L., Thalamic thermo-algesic transmission: ventral faxine extended release in the treatment of painful diabetic neuropathy: posterior (VP) complex versus VMpo in the light of a thalamic infarct a double-blind, placebo-controlled study’’ [Pain 110 (2004) 697-706}, with central pain, 113 223 113 248 Moore, J.E., see Von Korff, M., 113 323 Royal, M.A., see Dworkin, R.H., 113 9 Morgan, M.M., Clayton, C.C., Boyer-Quick, J.S., Differential susceptibility Ruehlman, L.S., Karoly, P., Newton, C., Aiken, L.S., The development and of the PAG and RVM to tolerance to the antinociceptive effect of preliminary validation of a brief measure of chronic pain impact for use morphine in the rat, 113 91 in the general population, 113 82 Nakagawasai, O., see Tan-No, K., 113 301 Sakurada, S., see Tan-No, K., 113 301 Nassar, M.A., see Stirling, L.C., 113 27 Sato, T., see Tan-No, K., 113 301 Neugebauer, V., see Han, J.S., 113 211 Satoh, S., see Tan-No, K., 113 301 Newton, C., see RuehIman, L.S., 113 82 Saunders, K., see Von Korff, M., 113 323 Nicholas, M.K., see Blyth, F.M., 113 285 Saunders, K., see Von Korff, M., 113 331 Nicol, G.D., see Fehrenbacher, J.C., 113 113 Schmelz, M., see Ikoma, A., 113 148 Niijima, F., see Tan-No, K., 113 301 Schmetterer, L., see Sycha, T., 113 316 Noguchi, K., see Mizushima, T., 113 51 Schreiber, S., see Peles, E., 113 340 Scorr, L., see Sternberg, W.F., 113 347 Oaklander, A.L., see Dey, D.D., 113 233 Sedan, O., Sprecher, E., Yarnitsky, D., Vagal stomach afferents inhibit Obata, H., Conklin, D., Eisenach, J.C., Spinal noradrenaline transporter somatic pain perception, 113 354 inhibition by reboxetine and Xen2174 reduces tactile hypersensitivity Simon, G., see Von Korff, M., 113 331 after surgery in rats, 113 271 Simon, L., see Dworkin, R.H., 113 9 Obata, K., see Mizushima, T., 113 51 Sindrup, S.H., see Bach, F.W., 113 245 Oberlander, T., see Grunau, R.E., 113 293 Smith, B.H., Elliott, A.M., Active self-management of chronic pain in the O'Neill, J.P., see Gilron, I., 113 191 community, 113 249 Orr, E., see Gilron, I., 113 19] Smith, L.D., see Sternberg, W.F., 113 347 Smith, M., see Paul, S.M., 113 37 Parada, C.A., Reichling, D.B., Levine, J.D., Chronic hyperalgesic priming Solimano, A., see Grunau, R.E., 113 293 in the rat involves a novel interaction between cAMP and PKCe second Sprecher, E., see Sedan, O., 113 354 messenger pathways, 113 185 Sprenger, T., Valet, M., Platzer, S., Pfaffenrath, V., Steude, U., Tolle, T.R.., Paul, S.M., Zelman, D.C., Smith, M., Miaskowski, C., Categorizing the SUNCT: bilateral hypothalamic activation during headache attacks and severity of cancer pain: further exploration of the establishment of resolving of symptoms after trigeminal decompression, 113 422 cutpoints, 113 37 Stang, P., see Von Korff, M., 113 331 Peles, E., Schreiber, S., Gordon, J., Adelson, M., Significantly higher Stauffer, J.W., see Dworkin, R.H., 113 9 methadone dose for methadone maintenance treatment (MMT) patients Stein, W., see Dworkin, R.H., 113 9 with chronic pain, 113 340 Sternberg, W.F., Scorr, L., Smith, L.D., Ridgway, C.G., Stout, M., Long- Persson, J., see Strigo, L.A., 113 255 term effects of neonatal surgery on adulthood pain behavior, 113 347 Peters, M.L., Vlaeyen, J.W.S., Weber, W.E.J., The joint contribution of Steude, U., see Sprenger, T., 113 422 physical pathology, pain-related fear and catastrophizing to chronic Stirling, L.C., Forlani, G., Baker, M.D., Wood, J.N., Matthews, E.A., Dick- back pain disability, 113 45 enson, A.H., Nassar, M.A., Nociceptor-specific gene deletion using Petersen, K.B., see Duedahl, T.H., 113 360 heterozygous Nay1.8-Cre recombinase mice, 113 27 Pfaffenrath, V., see Sprenger, T., 113 422 Stout, M., see Sternberg, W.F., 113 347 Platzer, S., see Sprenger, T., 113 422 Stovner, L.J., see Hagen, K., 113 416 Premkumar, L.S., see Raisinghani, M., 113 123 Strigo, I.A., Duncan, G.H., Bushnell, M.C., Boivin, M., Wainer, I., Rosas, Puehler, W., Brack, A., Kopf, A., Extensive abscess formation after M.E.R., Persson, J., The effects of racemic ketamine on painful stimu- repeated paravertebral injections for the treatment of chronic back lation of skin and viscera in human subjects, 113 255 pain, 113 427 Stucki, G., see Dworkin, R.H., 113 9 Sullivan, M.J.L., Lynch, M.E., Clark, A.J., Dimensions of catastrophic Quessy, S., see Dworkin, R.H., 113 9 thinking associated with pain experience and disability in patients with neuropathic pain conditions, 113 310 Raisinghani, M., Premkumar, L.S., Block of native and cloned vanilloid Svebak, S., see Hagen, K., 113 416 receptor | (TRPV1) by aminoglycoside antibiotics, 113 123 Sycha, T., Anzenhofer, S., Lehr, S., Schmetterer, L., Chizh, B., Eichler, Rappaport, B.A., see Dworkin, R.H., 113 9 H.-G., Gustorff, B., Rofecoxib attenuates both primary and secondary Rasmussen, P.V., see Bach, F.W., 113 245 inflammatory hyperalgesia: a randomized, double blinded, placebo Reichling, D.B., see Parada, C.A., 113 185 controlled crossover trial in the UV-B pain model, 113 316 Reid, G.J.. McGrath, P.J., Lang, B.A., Parent-child interactions among children with juvenile fibromyalgia, arthritis, and healthy controls, Tadano, T., see Tan-No, K., 113 301 113 201 Tait, R.C., see Chibnall, J.T., 113 369 Reuben, S.S., The prevention of post-surgical neuralgia, 113 242 Takahashi, H., see Tan-No, K., 113 301 Ridgway, C.G., see Sternberg, W.F., 113 347 Tan-No, K., Takahashi, H., Nakagawasai, O., Niijima, F., Sato, T., Satoh, Robbins, W., see Dworkin, R.H., 113 9 S., Sakurada, S., Marinova, Z., Yakovleva, T., Bakalkin, G., Terenius, Robinson, J.P., see Dworkin, R.H., 113 9 L., Tadano, T., Pronociceptive role of dynorphins in uninjured animals: Rodriguez Rosas, M.E., see Strigo, 1.A., 113 255 N-ethylmaleimide-induced nociceptive behavior mediated through Rollman, G.B., The need for ecological validity in studies of pain and inhibition of dynorphin degradation, 113 30] ethnicity, 113 3 Terenius, L., see Tan-No, K., 113 301 Romsing, J., see Duedahl, T.H., 113 360 Theodorou, V., see Ait-Belgnaoui, A., 113 141 Rothman, M., see Dworkin, R.H., 113 9 Thompson, E.N., Letter to the Editor of PAIN, 113 244 434 Author Index to Volume 113 (2005) 431-434 Tokunaga, A., see Mizushima, T., 113 51 Wainer, I., see Strigo, 1.A., 113 255 Tolle, T.R., see Sprenger, T., 113 422 Weber, W.E.J., see Peters, M.L., 113 45 Tollett, J., see Dworkin, R.H., 113 9 Weinberg, J., see Grunau, R.E., 113 293 Tramer, M.R., see Elia, N., 113 61 Wernicke, J., see Dworkin, R.H., 113 9 Tu, D., see Gilron, I., 113 191 Whitfield, M.F., see Grunau, R.E., 113 293 Turk, D.C., see Dworkin, R.H., 113 9 Wiesenfeld-Hallin, Z., see Wu, W.-P., 113 395 Turner, J.A., see Von Korff, M., 113 323 Witter, J., see Dworkin, R.H., 113 9 Wood, J.N., see Stirling, L.C., 113 27 Wu, W.-P., Hao, J.-X., Halldner, L., Lovdahl, C., DeLander, G.E., Wiesen- Valet, M., see Sprenger, T., 113 422 feld-Hallin, Z., Fredholm, B.B., Xu, X.-J., Increased nociceptive Van Houdenhove, B., Luyten, P., Beyond dualism: the role of life stress in response in mice lacking the adenosine A, receptor, 113 395 chronic pain, 113 238 Vasko, M.R., see Fehrenbacher, J.C., 113 113 Xu, X.-J., see Wu, W.-P., 113 395 Vinck, J., see Gheldof, E.L.M., 113 71 Vlaeyen, J.W.S., see Gheldof, E.L.M., 113 71 Yakovleva, T., see Tan-No, K., 113 301 Vlaeyen, J.W.S., see Peters, M.L., 113 45 Yamanaka, H., see Mizushima, T., 113 51 Von Korff, M., Balderson, B.H.K., Saunders, K., Miglioretti, D.L., Lin, Yarnitsky, D., see Sedan, O., 113 354 E.H.B., Berry, S., Moore, J.E., Turner, J.A., A trial of an activating Yu, W., see Grunau, R.E., 113 293 intervention for chronic back pain in primary care and physical therapy Yudashkin, M., see Eisenberg, E., 113 99 settings, 113 323 Zamora, J.E., see Gilron, I., 113 191 Von Korff, M., Crane, P., Lane, M., Miglioretti, D.L., Simon, G., Saunders, Zelman, D.C., see Paul, S.M., 113 37 K., Stang, P., Brandenburg, N., Kessler, R., Chronic spinal pain and Zhang, Y., see Ma, W., 113 386 physical—mental comorbidity in the United States: results from the Zhang, Y., see Martin, T.J., 113 376 national comorbidity survey replication, 113 331 Zwart, J.-A., see Hagen, K., 113 416 PAIN < =z Pain 113 (2005) 435-441 www.elsevier.com/locate/pain Subject Index to Volume 113 (2005) Abdominal constriction Arthritic pain Long-term effects of neonatal surgery on adulthood pain behavior, 113, mGluR! and mGluRS5 antagonists in the amygdala inhibit different 347 components of audible and ultrasonic vocalizations in a model of Abscess arthritic pain, 113, 211 Extensive abscess formation after repeated paravertebral injections for Assessment the treatment of chronic back pain, 113, 427 Core outcome measures for chronic pain clinical trials; IMMPACT Acceptance recommendations, 113, 9 Social context and acceptance of chronic pain: the role of solicitous and Audible vocalizations punishing responses, 113, 155 mGluR! and mGluRS5 antagonists in the amygdala inhibit different Addiction components of audible and ultrasonic vocalizations in a model of Significantly higher methadone dose for methadone maintenance treat- arthritic pain, 113, 211 ment (MMT) patients with chronic pain, 113, 340 Autonomic Adenylyl cyclase Neonatal procedural pain exposure predicts lower cortisol and beha- Chronic hyperalgesic priming in the rat involves a novel interaction vioral reactivity in preterm infants in the NICU, 113, 293 between cAMP and PKCe second messenger pathways, 113, 185 Adrenergic Autotomy Medium and large injured dorsal root ganglion cells increase TRPV-1, Central neuropathic itch from spinal-cord cavernous hemangioma: a accompanied by increased a2C-adrenoceptor co-expression and func- human case, a possible animal model, and hypotheses about pathogen- tional inhibition by clonidine, 113, 386 esis, 113, 233 Adverse events Axon reflex erythema Core outcome measures for chronic pain clinical trials: IMMPACT Electrically evoked itch in humans, 113, 148 recommendations, 113, 9 Back pain Affect A trial of an activating intervention for chronic back pain in primary mGluR! and mGluRS antagonists in the amygdala inhibit different care and physical therapy settings, 113, 323 components of audible and ultrasonic vocalizations in a model of Back pain arthritic pain, 113, 211 Chronic spinal pain and physical—mental comorbidity in the United Affective pain States: results from the national comorbidity survey replication, 113, Dimensions of catastrophic thinking associated with pain experience 331 and disability in patients with neuropathic pain conditions, 113, 310 Back pain Alloknesis Extensive abscess formation after repeated paravertebral injections for Electrically evoked itch in humans, 113, 148 the treatment of chronic back pain, 113, 427 Aminoglycoside antibiotics Behavior Block of native and cloned vanilloid receptor | (TRPV1) by aminogly- Intrathecal morphine and ketorolac analgesia after surgery: comparison coside antibiotics, 113, 123 of spontaneous and elicited responses in rats, 113, 376 Amygdala Behavioral models mGluR! and mGluRS5 antagonists in the amygdala inhibit different Social context and acceptance of chronic pain: the role of solicitous and components of audible and ultrasonic vocalizations in a model of punishing responses, 113, 155 arthritic pain, 113, 211 Analgesia Behaviour Chronic hyperalgesic priming in the rat involves a novel interaction Nociceptor-specific gene deletion using heterozygous Nay1.8-Cre between cAMP and PKCe second messenger pathways, 113, 185 recombinase mice, 113, 27 Analgesia Benzodiazepine Ketamine and postoperative pain — a quantitative systematic review of Significantly higher methadone dose for methadone maintenance treat- randomised trials, 113, 61 ment (MMT) patients with chronic pain, 113, 340 Analgesia Biopsychosocial model of chronic pain The effects of racemic ketamine on painful stimulation of skin and The joint contribution of physical pathology, pain-related fear and cata- viscera in human subjects, 113, 255 strophizing to chronic back pain disability, 113, 45 Animal model Bone metastasis Central neuropathic itch from spinal-cord cavernous hemangioma: a Categorizing the severity of cancer pain: further exploration of the human case, a possible animal model, and hypotheses about pathogen- establishment of cutpoints, 113, 37 esis, 113, 233 Brief screening Anti-hyperalgesia The development and preliminary validation of a brief measure of Intravenous dextromethorphan to human volunteers: relationship chronic pain impact for use in the general population, 113, 82 between pharmacokinetics and anti-hyperalgesic effect, 113, 360 doi: 10.1016/S0304-3959(04)0061 1-6 436 Subject Index to Volume 113 (2005) 435-441 Cancer pain Cognitive-behavioral Categorizing the severity of cancer pain: further exploration of the A trial of an activating intervention for chronic back pain in primary establishment of cutpoints, 113, 37 care and physical therapy settings, 113, 323 Capsaicin Colonic paracellular permeability Activation of p38 MAPK in primary afferent neurons by noxious stimu- Acute stress-induced hypersensitivity to colonic distension depends lation and its involvement in the development of thermal hyperalgesia, upon increase in paracellular permeability: role of myosin light chain 113, 51 kinase, 113, 141 Capsaicin Complex regional pain syndrome Block of native and cloned vanilloid receptor | (TRPV1) by aminogly- Evidence for cortical hyperexcitability of the affected limb representa- coside antibiotics, 113, 123 tion area in CRPS: a psychophysical and transcranial magnetic stimula- Capsaicin tion study, 113, 99 Medium and large injured dorsal root ganglion cells increase TRPV-1, Cortical excitability accompanied by increased a2C-adrenoceptor co-expression and func- Evidence for cortical hyperexcitability of the affected limb representa- tional inhibition by clonidine, 113, 386 tion area in CRPS: a psychophysical and transcranial magnetic stimula- Catastrophizing tion study, 113, 99 Confirmatory factor analysis of the Pain Catastrophizing Scale in Afri- Cortisol can American and Caucasian Workers’ Compensation claimants with Neonatal procedural pain exposure predicts lower cortisol and beha- low back injuries, 113, 369 vioral reactivity in preterm infants in the NICU, 113, 293 Catastrophizing CPCCOEt Dimensions of catastrophic thinking associated with pain experience mGluR1I and mGluRS5 antagonists in the amygdala inhibit different and disability in patients with neuropathic pain conditions, 113, 310 components of audible and ultrasonic vocalizations in a model of Catastrophizing arthritic pain, 113, 211 The joint contribution of physical pathology, pain-related fear and cata- Cre-loxP strophizing to chronic back pain disability, 113, 45 Nociceptor-specific gene deletion using heterozygous Nay1.8-Cre Cell culture recombinase mice, 113, 27 Enhanced excitability of dissociated primary sensory neurons after Cross-sectional chronic compression of the dorsal root ganglion in the rat, 113, 106 The differential role of pain, work characteristics and pain-related fear Central lateral nucleus in explaining back pain and sick leave in occupational settings, 113, 71 Activation of 5-HT,, and 5-HT; receptors in the parafascicular nucleus Cutpoints for pain severity suppresses the affective reaction of rats to noxious stimulation, 113, 405 Categorizing the severity of cancer pain: further exploration of the Central pain establishment of cutpoints, 113, 37 Thalamic thermo-algesic transmission: ventral posterior (VP) complex Cyclooxygenase versus VMpo in the light of a thalamic infarct with central pain, 113, Intrathecal morphine and ketorolac analgesia after surgery: comparison 993 of spontaneous and elicited responses in rats, 113, 376 Central sensitization Cyclooxygenase Electrically evoked itch in humans, 113, 148 Tumor necrosis factor a and interleukin-18 stimulate the expression of Chronic disease cyclooxygenase II but do not alter prostaglandin E, receptor mRNA Chronic spinal pain and physical—mental comorbidity in the United levels in cultured dorsal root ganglia cells, 113, 113 States: results from the national comorbidity survey replication, 113, Cytokine 33] Tumor necrosis factor a and interleukin-18 stimulate the expression of Chronic pain cyclooxygenase II but do not alter prostaglandin E, receptor mRNA A trial of an activating intervention for chronic back pain in primary levels in cultured dorsal root ganglia cells, 113, 113 care and physical therapy settings, 113, 323 Dextromethorphan Chronic pain Intravenous dextromethorphan to human volunteers: relationship Chronic hyperalgesic priming in the rat involves a novel interaction between pharmacokinetics and anti-hyperalgesic effect, 113, 360 between cAMP and PKCe second messenger pathways, 113, 185 Disability Chronic pain A trial of an activating intervention for chronic back pain in primary Chronic spinal pain and physical—mental comorbidity in the United care and physical therapy settings, 113, 323 States: results from the national comorbidity survey replication, 113, 331 Disability Chronic pain Chronic spinal pain and physical—mental comorbidity in the United Core outcome measures for chronic pain clinical trials: IMMPACT States: results from the national comorbidity survey replication, 113, recommendations, 113, 9 331 Chronic pain Disability Self-management of chronic pain: a population-based study, 113, 285 The joint contribution of physical pathology, pain-related fear and cata- Chronic pain strophizing to chronic back pain disability, 113, 45 Significantly higher methadone dose for methadone maintenance treat- Dorsal root ganglia ment (MMT) patients with chronic pain, 113, 340 Tumor necrosis factor a and interleukin-1f stimulate the expression of Chronic pain cyclooxygenase II but do not alter prostaglandin E, receptor mRNA Social context and acceptance of chronic pain: the role of solicitous and levels in cultured dorsal root ganglia cells, 113, 113 punishing responses, 113, 155 Dorsal root ganglion Chronic pain Activation of p38 MAPK in primary afferent neurons by noxious stimu- The development and preliminary validation of a brief measure of lation and its involvement in the development of thermal hyperalgesia, chronic pain impact for use in the general population, 113, 82 113, 5] Clinical trials Dorsal root ganglion Core outcome measures for chronic pain clinical trials: IMMPACT Enhanced excitability of dissociated primary sensory neurons after recommendations, 113, 9 chronic compression of the dorsal root ganglion in the rat, 113, 106 Subject Index to Volume 113 (2005) 435-441 437 Dorsal root ganglion Helplessness Medium and large injured dorsal root ganglion cells increase TRPV-1, Dimensions of catastrophic thinking associated with pain experience accompanied by increased a2C-adrenoceptor co-expression and func- and disability in patients with neuropathic pain conditions, 113, 310 tional inhibition by clonidine, 113, 386 Hot-plate Dynorphins Long-term effects of neonatal surgery on adulthood pain behavior, 113, Pronociceptive role of dynorphins in uninjured animals: N-ethylmalei- 347 mide-induced nociceptive behavior mediated through inhibition of Hyperalgesia dynorphin degradation, 113, 301 Increased nociceptive response in mice lacking the adenosine A, recep- Emotional burden tor, 113, 395 The development and preliminary validation of a brief measure of Hyperexcitability chronic pain impact for use in the general population, 113, 82 Enhanced excitability of dissociated primary sensory neurons after Emotional functioning chronic compression of the dorsal root ganglion in the rat, 113, 106 Core outcome measures for chronic pain clinical trials: IMMPACT Hypothalamus recommendations, 113, 9 SUNCT: bilateral hypothalamic activation during headache attacks and Epidemiology resolving of symptoms after trigeminal decompression, 113, 422 Do high TSH values protect against chronic musculoskeletal Hysterectomy complaints? The Nord-Tr@ndelag Health Study (HUNT), 113, 416 A placebo-controlled randomized clinical trial of perioperative Epidemiology administration of gabapentin, rofecoxib and their combination for spon- Self-management of chronic pain: a population-based study, 113, 285 taneous and movement-evoked pain after abdominal hysterectomy, ERK 113, 191 Activation of p38 MAPK in primary afferent neurons by noxious stimu- Immunocytochemistry lation and its involvement in the development of thermal hyperalgesia, Medium and large injured dorsal root ganglion cells increase TRPV-1, 113, 51 accompanied by increased a2C-adrenoceptor co-expression and func- Evoked potential tional inhibition by clonidine, 113, 386 Thalamic thermo-algesic transmission: ventral posterior (VP) complex Inflammation versus VMpo in the light of a thalamic infarct with central pain, 113, Chronic hyperalgesic priming in the rat involves a novel interaction 223 between cAMP and PKCée second messenger pathways, 113, 185 Excessive grooming Inflammation Central neuropathic itch from spinal-cord cavernous hemangioma: a Increased nociceptive response in mice lacking the adenosine A, recep- human case, a possible animal model, and hypotheses about pathogen- tor, 113, 395 esis, 113, 233 Inflammation Experimental pain Overexpression of NGF or GDNF alters transcriptional plasticity Ethnic differences in responses to multiple experimental pain stimuli, evoked by inflammation, 113, 277 113, 20 Intracellular calcium Experimental pain Medium and large injured dorsal root ganglion cells increase TRPV-1, Gender differences in pain modulation evoked by repeated injections of accompanied by increased a2C-adrenoceptor co-expression and func- glutamate into the human trapezius muscle, 113, 134 tional inhibition by clonidine, 113, 386 Experimental pain model Intralaminar thalamus Intravenous dextromethorphan to human volunteers: relationship Activation of 5-HT,, and 5-HT> receptors in the parafascicular nucleus between pharmacokinetics and anti-hyperalgesic effect, 113, 360 suppresses the affective reaction of rats to noxious stimulation, 113, 405 Facial reactivity Intrathecal Neonatal procedural pain exposure predicts lower cortisol and beha- Spinal noradrenaline transporter inhibition by reboxetine and Xen2174 vioral reactivity in preterm infants in the NICU, 113, 293 reduces tactile hypersensitivity after surgery in rats, 113, 271 Fibromyalgia Intrathecal administration Parent—child interactions among children with juvenile fibromyalgia, Pronociceptive role of dynorphins in uninjured animals: N-ethylmalei- arthritis, and healthy controls, 113, 201 mide-induced nociceptive behavior mediated through inhibition of fMRI dynorphin degradation, 113, 301 SUNCT: bilateral hypothalamic activation during headache attacks and Irritable bowel syndrome resolving of symptoms after trigeminal decompression, 113, 422 Characteristics of rectal perception are altered in irritable bowel Gabapentin syndrome, 113, 160 A placebo-controlled randomized clinical trial of perioperative Jannetta procedure administration of gabapentin, rofecoxib and their combination for spon- SUNCT: bilateral hypothalamic activation during headache attacks and taneous and movement-evoked pain after abdominal hysterectomy, resolving of symptoms after trigeminal decompression, 113, 422 113, 191 Job stress Global ratings The differential role of pain, work characteristics and pain-related fear Core outcome measures for chronic pain clinical trials; IMMPACT in explaining back pain and sick leave in occupational settings, 113, 71 recommendations, 113, 9 Juvenile rheumatoid arthritis Growth factors Parent-child interactions among children with juvenile fibromyalgia, Overexpression of NGF or GDNF alters transcriptional plasticity arthritis, and healthy controls, 113, 201 evoked by inflammation, 113, 277 Knock-out Health-related quality of life Nociceptor-specific gene deletion using heterozygous Nay!.8-Cre Core outcome measures for chronic pain clinical trials: IMMPACT recombinase mice, 113, 27 recommendations, 113, 9 Laser-evoked potential Heat Thalamic thermo-algesic transmission: ventral posterior (VP) complex The effects of racemic ketamine on painful stimulation of skin and versus VMpo in the light of a thalamic infarct with central pain, 113, viscera in human subjects, 113, 255 223 438 Subject Index to Volume 113 (2005) 435-441 Low back pain Neonatal surgery Confirmatory factor analysis of the Pain Catastrophizing Scale in Afri- Long-term effects of neonatal surgery on adulthood pain behavior, 113, can American and Caucasian Workers’ compensaiion claimants with 347 low back injuries, 113, 369 N-ethylmaleimide Low back pain Pronociceptive role of dynorphins in uninjured animals: N-ethylmalei- The differential role of pain, work characteristics and pain-related fear mide-induced nociceptive behavior mediated through inhibition of in explaining back pain and sick leave in occupational settings, 113, 71 dynorphin degradation, 113, 301 Measurement Neuropathic pain Confirmatory factor analysis of the Pain Catastrophizing Scale in Afri- Dimensions of catastrophic thinking associated with pain experience can American and Caucasian Workers’ compensation claimants with and disability in patients with neuropathic pain conditions, 113, 310 iow back injuries, 113, 369 Neuropathic pain Medial thalamus Enhanced excitability of dissociated primary sensory neurons after Activation of 5-HT,, and 5-HT> receptors in the parafascicular nucleus chronic compression of the dorsal root ganglion in the rat, 113, 106 suppresses the affective reaction of rats to noxious stimulation, 113, 405 Neuropathic pain Mental disorders Increased nociceptive response in mice lacking the adenosine A, recep- Chronic spinal pain and physical—mental comorbidity in the United tor, 113, 395 States: results from the national comorbidity survey replication, 113, NMDA-R 331 The effects of racemic ketamine on painful stimulation of skin and Meta-analysis viscera in human subjects, 113, 255 Ketamine and postoperative pain — a quantitative systematic review of N-methyl-D-aspartate receptor ion-channel complex randomised trials, 113, 61 Pronociceptive role of dynorphins in uninjured animals: N-ethylmalei- Metabotropic glutamate receptors mide-induced nociceptive behavior mediated through inhibition of mGluR1I and mGluRS5 antagonists in the amygdala inhibit different dynorphin degradation, 113, 301 components of audible and ultrasonic vocalizations in a model of Nociception arthritic pain, 113, 211 Electrically evoked itch in humans, 113, 148 Methadone dosage Nociception Significantly higher methadone dose for methadone maintenance treat- Increased nociceptive response in mice lacking the adenosine A, recep- ment (MMT) patients with chronic pain, 113, 340 tor, 113, 395 Methadone maintenance treatment (MMT) Nociception Significantly higher methadone dose for methadone maintenance treat- mGluR! and mGluRS5 antagonists in the amygdala inhibit different ment (MMT) patients with chronic pain, 113, 340 components of audible and ultrasonic vocalizations in a model of Mice arthritic pain, 113, 211 Increased nociceptive response in mice lacking the adenosine A, recep- Nociception tor, 113, 395 Overexpression of NGF or GDNF alters transcriptional plasticity MLCK evoked by inflammation, 113, 277 Acute stress-induced hypersensitivity to colonic distension depends Nociception upon increase in paracellular permeability: role of myosin light chain Thalamic thermo-algesic transmission: ventral posterior (VP) complex kinase, 113, 141 versus VMpo in the light of a thalamic infarct with central pain, 113, Morphine 223 Increased nociceptive response in mice lacking the adenosine A, recep- Nociception tor, 113, 395 The effect on mechanical pain threshold over human muscles by oral Morphine administration of granisetron and diclofenac-sodium, 113, 265 Neonatal procedural pain exposure predicts lower cortisol and beha- Nociception vioral reactivity in preterm infants in the NICU, 113, 293 The effects of racemic ketamine on painful stimulation of skin and Movement-evoked pain viscera in human subjects, 113, 255 A placebo-controlled randomized clinical trial of perioperative Nociceptive behavior administration of gabapentin, rofecoxib and their combination for spon- Pronociceptive role of dynorphins in uninjured animals: N-ethylmalei- taneous and movement-evoked pain after abdominal hysterectomy, mide-induced nociceptive behavior mediated through inhibition of 113, 191 dynorphin degradation, 113, 301 MPEP Noradrenaline transporter mGluR! and mGluRS5 antagonists in the amygdala inhibit different Spinal noradrenaline transporter inhibition by reboxetine and Xen2174 components of audible and ultrasonic vocalizations in a model of reduces tactile hypersensitivity after surgery in rats, 113, 271 arthritic pain, 113, 211 8-OH-DPAT Multidisciplinary treatment Activation of 5-HT,, and 5-HT> receptors in the parafascicular nucleus Social context and acceptance of chronic pain: the role of solicitous and suppresses the affective reaction of rats to noxious stimulation, 113, 405 punishing responses, 113, 155 Opiate Musculoskeletal Differential susceptibility of the PAG and RVM to tolerance to the Do high TSH values protect against chronic musculoskeletal antinociceptive effect of morphine in the rat, 113, 91 complaints? The Nord-Tréndelag Health Study (HUNT), 113, 416 Opioid receptor Neck pain Intrathecal morphine and ketorolac analgesia after surgery: comparison Chronic spinal pain and physical—mental comorbidity in the United of spontaneous and elicited responses in rats, 113, 376 States: results from the national comorbidity survey replication, 113, 33] Outcomes Core outcome measures for chronic pain clinical trials:s IMMPACT Neomycin recommendations, 113, 9 Block of native and cloned vanilloid receptor | (TRPV1) by aminoglycoside antibiotics, 113, 123 Subject Index to Volume 113 (2005) 435-44] p38 Pharmacokinetics—pharmacodynamics Activation of p38 MAPK in primary afferent neurons by noxious stimu- Intravenous dextromethorphan to human volunteers: relationship lation and its involvement in the development of thermal hyperalgesia, between pharmacokinetics and anti-hyperalgesic effect, 113, 360 113, 5! Physical functioning Pain Core outcome measures for chronic pain clinical trials: IMMPACT Activation of 5-HT,, and 5-HT; receptors in the parafascicular nucleus recommendations, 113, 9 suppresses the affective reaction of rats to noxious stimulation, 113, 405 Physical pathology Pain The joint contribution of physical pathology, pain-related fear and catastrophizing to chronic back pain disability, 113, 45 Central neuropathic itch from spinal-cord cavernous hemangioma: a human case, a possible animal model, and hypotheses about pathogen- Physical therapy esis, 113, 233 A trial of an activating intervention for chronic back pain in primary Pain care and physical therapy settings, 113, 323 Plasticity Characteristics of rectal perception are altered in irritable bowel syndrome, 113, 160 Overexpression of NGF or GDNF alters transcriptional plasticity evoked by inflammation, 113, 277 Pain Posterior part of the ventral medial nucleus (VMpo) Ketamine and postoperative pain — a quantitative systematic review of Thalamic thermo-algesic transmission: ventral posterior (VP) complex randomised trials, 113, 61 versus VMpo in the light of a thalamic infarct with central pain, 113, Pain 223 Neonatal procedural pain exposure predicts lower cortisol and beha- Postoperative vioral reactivity in preterm infants in the NICU, 113, 293 Ketamine and postoperative pain — a quantitative systematic review of Pain randomised trials, 113, 61 Nociceptor-specific gene deletion using heterozygous Nay1.8-Cre Postoperative pain recombinase mice, 113, 27 A placebo-controlled randomized clinical trial of perioperative Pain administration of gabapentin, rofecoxib and their combination for spon- Overexpression of NGF or GDNF alters transcriptional plasticity taneous and movement-evoked pain after abdominal hysterectomy, evoked by inflammation, 113, 277 113, 191 Pain Postoperative pain Vagal stomach afferents inhibit somatic pain perception, 113, 354 Spinal noradrenaline transporter inhibition by reboxetine and Xen2174 Pain Catastrophizing Scale reduces tactile hypersensitivity after surgery in rats, 113, 27] Confirmatory factor analysis of the Pain Catastrophizing Scale in Afri- Postoperative pain can American and Caucasian Workers’ compensation claimants with Intrathecal morphine and ketorolac analgesia after surgery: comparison low back injuries, 113, 369 of spontaneous and elicited responses in rats, 113, 376 Pain habituation Pressure Gender differences in pain modulation evoked by repeated injections of The effects of racemic ketamine on painful stimulation of skin and glutamate into the human trapezius muscle, 113, 134 viscera in human subjects, 113, 255 Pain intensity Pressure pain threshold The joint contribution of physical pathology, pain-related fear and cata- Gender differences in pain modulation evoked by repeated injections of strophizing to chronic back pain disability, 113, 45 glutamate into the human trapezius muscle, 113, 134 Pain interference Preterm infant The development and preliminary validation of a brief measure of Neonatal procedural pain exposure predicts lower cortisol and beha- chronic pain impact for use in the general population, 113, 82 vioral reactivity in preterm infants in the NICU, 113, 293 Pain-related fear Prevalence The differential role of pain, work characteristics and pain-related fear Chronic spinal pain and physical—mental comorbidity in the United in explaining back pain and sick leave in occupational settings, 113, 71 States: results from the national comorbidity survey replication, 113, 331 Pain-related fear Prevalence The joint contribution of physical pathology, pain-related fear and cata- Significantly higher methadone dose for methadone maintenance treat- strophizing to chronic back pain disability, 113, 45 ment (MMT) patients with chronic pain, 113, 340 Pain severity Primary care The development and preliminary validation of a brief measure of A trial of an activating intervention for chronic back pain in primary chronic pain impact for use in the general population, 113, 82 care and physical therapy settings, 113, 323 Pain threshold Prodynorphin knockout mice The effect on mechanical pain threshold over human muscles by oral Pronociceptive role of dynorphins in uninjured animals: N-ethylmalei- administration of granisetron and diclofenac-sodium, 113, 265 mide-induced nociceptive behavior mediated through inhibition of Parasympathetic dynorphin degradation, 113, 301 Vagal stomach afferents inhibit somatic pain perception, 113, 354 Prostaglandin E, Paravertebral injection The effect on mechanical pain threshold over human muscles by oral Extensive abscess formation after repeated paravertebral injections for administration of granisetron and diclofenac-sodium, 113, 265 the treatment of chronic back pain, 113, 427 Prostaglandin E, Parent—child interactions Tumor necrosis factor a and interleukin-18 stimulate the expression of Parent—child interactions among children with juvenile fibromyalgia, cyclooxygenase II but do not alter prostaglandin E, receptor mRNA arthritis, and healthy controls, 113, 201 levels in cultured dorsal root ganglia cells, 113, 113 Peripheral nerve Prostaglandin receptor Medium and large injured dorsal root ganglion cells increase TRPV-1, Tumor necrosis factor a and interleukin-18 stimulate the expression of accompanied by increased a2C-adrenoceptor co-expression and func- cyclooxygenase II but do not alter prostaglandin E, receptor mRNA tional inhibition by clonidine, 113, 386 levels in cultured dorsal root ganglia cells, 113, 113 440 Subject Index to Volume 113 (2005) 435-441 Pruritus Skeletal muscle Central neuropathic itch from spinal-cord cavernous hemangioma: a The effect on mechanical pain threshold over human muscles by oral human case, a possible animal model, and hypotheses about pathogen- administration of granisetron and diclofenac-sodium, 113, 265 esis, 113, 233 Social influences Pruritus Social context and acceptance of chronic pain: the role of solicitous and Electrically evoked itch in humans, 113, 148 punishing responses, 113, 155 Psychophysics Sodium channel Characteristics of rectal perception are altered in irritable bowel Nociceptor-specific gene deletion using heterozygous Nay1!.8-Cre syndrome, 113, 160 recombinase mice, 113, 27 Psychophysics Spinal analgesia The effects of racemic ketamine on painful stimulation of skin and Intrathecal morphine and ketorolac analgesia after surgery: comparison viscera in human subjects, 113, 255 of spontaneous and elicited responses in rats, 113, 376 Quantitative sensory testing Spinal cord injury Evidence for cortical hyperexcitability of the affected limb representa- Central neuropathic itch from spinal-cord cavernous hemangioma: a tion area in CRPS: a psychophysical and transcranial magnetic stimula- human case, a possible animal model, and hypotheses about pathogen- tion study, 113, 99 esis, 113, 233 Race Spinal projection Confirmatory factor analysis of the Pain Catastrophizing Scale in Afri- Thalamic thermo-algesic transmission: ventral posterior (VP) complex can American and Caucasian Workers’ compensation claimants with versus VMpo in the light of a thalamic infarct with central pain, 113, low back injuries, 113, 369 993 Randomized controlled trials Spontaneous activity Core outcome measures for chronic pain clinical trials:) IMMPACT Enhanced excitability of dissociated primary sensory neurons after recommendations, 113, 9 chronic compression of the dorsal root ganglion in the rat, 113, 106 Rats Stress Spinal noradrenaline transporter inhibition by reboxetine and Xen2174 Acute stress-induced hypersensitivity to colonic distension depends reduces tactile hypersensitivity after surgery in rats, 113, 271 upon increase in paracellular permeability: role of myosin light chain Reboxetine kinase, 113, 141 Spinal noradrenaline transporter inhibition by reboxetine and Xen2174 Stress reduces tactile hypersensitivity after surgery in rats, 113, 27] Neonatal procedural pain exposure predicts lower cortisol and beha- Rectum vioral reactivity in preterm infants in the NICU, 113, 293 Characteristics of rectal perception are altered in irritable bowel SUNCT syndrome, 113, 160 SUNCT: bilateral hypothalamic activation during headache attacks and Repetitive strain resolving of symptoms after trigeminal decompression, 113, 422 Chronic hyperalgesic priming in the rat involves a novel interaction Surgery between cAMP and PKCe second messenger pathways, 113, 185 Ketamine and postoperative pain — a quantitative systematic review of Rofecoxib randomised trials, 113, 61 A placebo-controlled randomized clinical trial of perioperative Survey administration of gabapentin, rofecoxib and their combination for spon- Chronic spinal pain and physical—mental comorbidity in the United taneous and movement-evoked pain after abdominal hysterectomy, States: results from the national comorbidity survey replication, 113, 113, 191 331 SB-269970 Systematic review Activation of 5-HT,, and 5-HT; receptors in the parafascicular nucleus Ketamine and postoperative pain — a quantitative systematic review of suppresses the affective reaction of rats to noxious stimulation, 113, 405 randomised trials, 113, 61 Self-care Tail-withdrawal Self-management of chronic pain: a population-based study, 113, 285 Long-term effects of neonatal surgery on adulthood pain behavior, 113, Self-management 347 A trial of an activating intervention for chronic back pain in primary Temporal summation care and physical therapy settings, 113, 323 Sensory neuron Gender differences in pain modulation evoked by repeated injections of glutamate into the human trapezius muscle, 113, 134 Tumor necrosis factor a and interleukin-18 stimulate the expression of cyclooxygenase II but do not alter prostaglandin E, receptor mRNA Thermal stimuli levels in cultured dorsal root ganglia cells, 113, 113 Activation of p38 MAPK in primary afferent neurons by noxious stimu- Sequential analyses lation and its involvement in the development of thermal hyperalgesia, Parent—child interactions among children with juvenile fibromyalgia, 113, 51 arthritis, and healthy controls, 113, 201 Thyroid dysfunction Serotonin 5-HT; antagonist Do high TSH values protect against chronic musculoskeletal The effect on mechanical pain threshold over human muscles by oral complaints? The Nord-Tr@ndelag Health Study (HUNT), 113, 416 administration of granisetron and diclofenac-sodium, 113, 265 Transcranial magnetic stimulation Sex difference Evidence for cortical hyperexcitability of the affected limb representa- The effect on mechanical pain threshold over human muscles by oral tion area in CRPS: a psychophysical and transcranial magnetic stimula- administration of granisetron and diclofenac-sodium, 113, 265 tion study, 113, 99 Sex differences Transcription Gender differences in pain modulation evoked by repeated injections of Overexpression of NGF or GDNF alters transcriptional plasticity glutamate into the human trapezius muscle, 113, 134 evoked by inflammation, 113, 277 Sick leave Trigeminal autonomic cephalgia The differential role of pain, work characteristics and pain-related fear SUNCT: bilateral hypothalamic activation during headache attacks and in explaining back pain and sick leave in occupational settings, 113, 71 resolving of symptoms after trigeminal decompression, 113, 422